disulfiram has been researched along with Cancer of Testis in 2 studies
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mego, M | 1 |
| Svetlovska, D | 1 |
| Kalavska, K | 1 |
| Lesko, P | 1 |
| Makovník, M | 1 |
| Obertova, J | 1 |
| Orszaghova, Z | 1 |
| Palacka, P | 1 |
| Rečková, M | 1 |
| Rejlekova, K | 1 |
| Z, SM | 1 |
| Mardiak, J | 1 |
| Chovanec, M | 1 |
| Yuan, M | 1 |
| Wu, Q | 1 |
| Zhang, M | 1 |
| Lai, M | 1 |
| Chen, W | 1 |
| Yang, J | 1 |
| Jiang, L | 1 |
| Cao, J | 1 |
1 trial available for disulfiram and Cancer of Testis
| Article | Year |
|---|---|
Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disulfiram; Drug Resistance, Neoplasm; Hu | 2022 |
1 other study available for disulfiram and Cancer of Testis
| Article | Year |
|---|---|
Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Topics: Alcoholism; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disul | 2023 |